¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"terminal breathing"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • nose breathing
    ÄÚÈ£Èí
  • positive pressure breathing
    ¾ç¾ÐÈ£Èí(¹ý)
  • pressure breathing
    °¡¾ÐÈ£Èí(¹ý)
  • pressure breathing assister
    °¡¾ÐÈ£Èíº¸Á¶±â
  • paradoxical breathing
    ¿ª¼³È£Èí
  • percentage breathing
    ¹éºÐÀ²È£Èí
  • periodic breathing
    Áֱ⺯µ¿È£Èí
  • spontaneous breathing
    ÀÚ¹ßÈ£Èí
  • stertorous breathing
    ÄÚ°ñ±âÈ£Èí
  • stridulous breathing
    ±×··°Å¸²È£Èí
  • shallow breathing
    ¾èÀºÈ£Èí
  • vesicular breathing
    ÆóÆ÷È£ÈíÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • postsynaptic terminal
    ¿¬Á¢ÈÄÁ¾¸»
  • presynaptic terminal
    ¿¬Á¢ÀüÁ¾¸»
  • terminal stage
    ¸»±â
  • terminal sulcus
    ºÐ°è°í¶û
  • terminal
    ³¡¸Ó¸®, Á¾¸», ¸»´Ü
  • terminal ventricle
    ô¼ö³ú½Ç
  • terminal villus
    Á¾¸»À¶¸ð
  • terminal respiratory unit
    Á¾¸»È£Èí´ÜÀ§
  • breathing apparatus
    È£Èí±â±¸
  • pressure breathing assister
    °¡¾ÐÈ£Èíº¸Á¶±â
  • breathing
    ¼û½¬±â, È£Èí
  • breathing capacity
    È£Èí¿ëÀû
  • breathing exercise
    È£Èí¿îµ¿
  • breathing ferment
    È£Èí¹ßÈ¿¼Ò
  • breathing mask
    È£Èí¸¶½ºÅ©
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • mouth breathing
    ±¸°­È£Èí.
  • mouth to mask breathing
    ÀÔ°ú ¸¶½ºÅ© ÀΰøÈ£Èí(¹ý)(¡­ìÑÍïû¼ýåÛö).
  • mouth to mouth breathing
    Á¢±¸ÀΰøÈ£Èí(ïÈÏ¢ìÑÍïû¼ýå).
  • mouth to nose breathing
    ÀÔ°úÄÚ ÀΰøÈ£Èí(¹ý), ±¸ºñ(½Ä) ÀΰøÈ£Èí(¹ý).
  • nasal alar breathing
    ºñÀÍÈ£Èí
  • nasal breathing
    ºñÈ£Èí, ÄÚÈ£Èí
  • negative pressure breathing
    À½¾ÐÈ£Èí.
  • negative pressure breathing
    À½¾ÐÈ£Èí.
  • nose breathing
    ºñÈ£Èí
  • oral respiration =mouth breathing
    ÀÔÈ£Èí.
  • paradoxic breathing
  • paradoxical breathing
    ±âÀÌÈ£Èí(Ðôì¶û¼ýå).
  • percentage breathing
    ¹éºÐÀ²È£Èí.
  • periodic breathing
    Áֱ⼺ º¯µ¿È£Èí.
  • positive pressure breathing
    ¾ç¾ÐÈ£Èí(¹ý).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Terminal ganglion
    Á¾¸»½Å°æÀý
    [¿¾ ¿ë¾î] Á¾½Å°æÀý
  • Terminal glial cell
    Á¾¸»¾Æ±³¼¼Æ÷
    [¿¾ ¿ë¾î] Á¾¸»±³¼¼Æ÷
  • Terminal villi
    Á¾¸»À¶¸ð
    [¿¾ ¿ë¾î] Á¾¸»À¶¸ð
  • Terminal villus
    Á¾¸»À¶¸ð
    [¿¾ ¿ë¾î] Á¾¸»À¶¸ð
  • Lanceolate terminal of hair follicle
    ÅÐÁÖ¸Ó´ÏÁ¾¸»
    [¿¾ ¿ë¾î] ¸ð³¶Á¾¸»
  • Encapsulated nerve terminal
    ÇǸ·½Å°æ¼Òü
    [¿¾ ¿ë¾î] ÇǸ·Ã˼Òü
  • Cutaneous nerve terminal
    ÇǺνŰæÁ¾¸» (¢Ñ ½Å°æÁ¾¸»)
    [¿¾ ¿ë¾î] ÇǺνŰæÁ¾¸»
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
DNTT terminal deoxynucleotidyltransferase
ERT esophageal radionuclide transit; estrogen replacement therapy; examination room terminal; external r...
ET educational therapy; effective temperature; ejection time; embryo transfer; endothelin; endotoxin; e...
Fd the amino-terminal portion of the heavy chain of an immunoglobulin molecule; ferredoxin
FTIR Fourier-transformed infrared; functional terminal innervation ratio
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
TBFVL Tidal breathing flow-volume loops
WOB Work of breathing
B breathing
QB quiet breathing
SB spontaneous breathing
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • costal breathing
    ´Á°ñ È£Èí
  • deep breathing
    ½ÉÈ£Èí
  • expired air breathing
    È£±â È£Èí¹ý
  • frog breathing
    °³±¸¸® È£Èí
    È£Èí ¿îµ¿±ÙÀ̳ª È£Èí ¿îµ¿ º¸Á¶±ÙÀÇ µµ¿ò ¾øÀÌ ÇàÇØÁö´Â È£ÈíÀ¸·Î, ÀεαÙÀÌ Çô¸¦ ÀÌ¿ëÇÏ¿© °ø±â°¡ ±Þ¼ÓÇÏ°Ô ÈíÀεȴÙ. ÀÌ·± È£ÈíÀº ¸¸¼º ±Ù¸¶ºñ ȯÀÚÀÇ ÆóȰ·®À» Áõ´ë½ÃŰ´Â ¸ñÀûÀ¸·Î ÇàÇØÁø´Ù.
  • intermittent positive pressure breathing
    °£ÇæÀû Á¤¾Ð È£Èí¹ý
    ¼øÈ¯ÆÇÀ¸·ÎºÎÅÍÀÇ ÀÏÁ¤ ¾Ð·ÂÇÏ¿¡¼­ ÈíÀÔÇÏ´Â µ¿¾È¿¡ Æó°¡ ÀÚµ¿ÀûÀ¸·Î ÆØÃ¢ÇÏ´Â °Í.
  • mouth temperature wax :

    mouth to mask breathing

    ÀÔ°ú ¸¶½ºÅ© Àΰø È£Èí, ÀÔ°ú ¸¶½ºÅ© Àΰø È£Èí¹ý
  • mouth-to-nose breathing
    ÀÔ°ú ÄÚ Àΰø È£Èí, ÀÔ°ú ÄÚ Àΰø È£Èí¹ý, ±¸ºñ Àΰø ȣȩ, ±¸ºñ½Ä Àΰø È£Èí, ±¸ºñ½Ä Àΰø È£Èí¹ý
  • negative pressure breathing
    À½¾Ð È£Èí
  • percentage breathing
    ¹éºÐÀ² È£Èí
  • periodic breathing
    ÁÖ±â È£Èí
    ¾î¶² ÀÏÁ¤ÇÑ Áֱ⸦ Áö´Ï°í ¹Ýº¹Çϴ ȣÈí ÀÌ»óÀÌ´Ù. ´ëÇ¥ÀûÀÎ °ÍÀÌ Ã¼ÀνºÅäÅ©½º È£Èí, ºñ¿À È£ÈíÀÌ´Ù. ÀüÀÚ´Â ÁßÁõ ½ÉºÎÀüÀ̳ª ¿äµ¶Áõ µî¿¡¼­ ³ªÅ¸³ª´Â °ÍÀ¸·Î È£ÈíÀÇ ¼ö³ª ±íÀ̰¡ Â÷Ãû Áõ°¡ÇÏ°í ´ÙÀ½¿¡ °¨¼ÒÇØ¼­ ÀϽà ȣÈíÀÌ Á¤ÁöÇÏ´Â »çÀÌŬÀÌ ¹Ýº¹µÇ´Â °ÍÀÌ´Ù. ÈÄÀÚ´Â ³ú ¹× ³ú¸· Áúȯ¿¡¼­ ¸¹ÀÌ º¸°Ô µÈ´Ù. ¿Ï¸¸ÇÑ È£ÈíÀÌ ¹ø°¥¾Æ ³ªÅ¸³ª´Â °ÍÀÌ´Ù.
  • shallow breathing
    ¾èÀº È£Èí
    È£ÈíÀÌ ¾è°í ºü¸¥ °Í.
  • spontaneous breathing
    ÀÚ¿¬ È£Èí
  • work of breathing
    È£ÈíÀ» À§ÇÑ ÀÏ ¸¶Ãë
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
RNA 3'-terminal phosphate cyclase <enzyme> ATP dependent; forms 2',3' terminal cyclic phosphate on RNA which is then the substrate for RNA ligase of hela cells
Registry number: EC 6.5.-
Synonym: RNA tph cyclase
(26 Jun 1999)
c-Jun amino-terminal kinase <enzyme> A stress-activated protein kinase; 46-kD kinase that phosphorylates ser(63) and ser(73) of c-jun; similar to yeast hog1 kinase; amino acid sequence given in second source; genbank l23118
Registry number: EC 2.7.10.-
Synonym: jn kinase, jnk1 protein kinase, jnk-46, jnk1 protein, jun-nh2-terminal kinase, stress-activated protein kinase 1, sap kinase-1, sapk1, p46 sap kinase, c-jun kinase-1
(26 Jun 1999)
photosystem II D1 polypeptide carboxy-terminal processing protease <enzyme> From thylakoids; not inhibited by common protease inhibitors
Registry number: EC 3.4.99.-
Synonym: d1 carboxy-terminal processing protease, d1 c-terminal protease, ctpa gene product
(26 Jun 1999)
COOH-terminal signal transamidase <enzyme> Present in the endoplasmic reticulum; catalyses concomitant cleavage of the signal peptide of nascent proteins destined to be processed to a glycosylphosphatidylinositol (gpi) and addition of the gpi anchor
Registry number: EC 2.3.2.-
Synonym: cooh-ts-transamidase, gpi transamidase, gpti transamidase
(26 Jun 1999)
C-terminal leucine protein methyltransferase <enzyme> Reversibly modifies protein phosphatase 2a by methyl esterification at its c-terminal leucine residues
Registry number: EC 2.1.1.-
Synonym: tlp methyltransferase
(26 Jun 1999)
protein NH2-terminal asparagine deamidase <enzyme> Converts amino terminal asparagine to aspartic acid; from porcine liver; mw about 33 kD
Registry number: EC 3.5.1.-
Synonym: porcine pnad
(26 Jun 1999)
protein N-terminal acetyltransferase <enzyme> From saccharmyces cerevisiae; encodes a catalytic subunit of an n-terminal acetyltransferase; ard1 and nat1 proteins are subunits of this enzyme
Registry number: EC 2.3.1.-
Synonym: nat1 gene protein, saccharomyces, yeast protein n-terminal acetyltransferase, n-terminal protein acetyltransferase, ard1 protein
(26 Jun 1999)
HIV long-terminal repeat Regulatory sequences important for viral replication that are located on each end of the HIV genome. The ltr includes the HIV enhancer, promoter, and other sequences. Specific regions in the ltr include the negative regulatory element (nre), nf-kappa b binding sites , sp1 binding sites, tata box, and trans-acting responsive element (tar). The binding of both cellular and viral proteins to these regions regulates HIV transcription.
(12 Dec 1998)
small bowel disease involving terminal ileum <radiology> Crohn's, TB, Yersinia
(12 Dec 1998)
NH2-terminal <biochemistry> The end of a protein or polypeptide chain with the unattached amino group or the aminoacyl residue containing it.
Each amino acid in the chain has an amino group on one side, which is attached to the carboxyl group (COOH group) of the previous amino acid, and a carboxyl group on the other side (which is attached to the amino group of the next amino acid). The other end of the polypeptide chain is called the carboxyl terminal.
Synonym: NH2-terminal.
(14 Aug 2000)
Deiters' terminal frames Platelike structures in the organ of Corti uniting the outer phalangeal cells with Hensen's cells.
(05 Mar 2000)
direct terminal repeat A particular sequence of nucleotides which appears on both ends of a DNA or RNA molecule.
(09 Oct 1997)
ileitis, terminal Crohn's disease, a chronic inflammatory disease of the intestine involving only the end of the small intestine (the terminal ileum). Crohn's disease affects primarily the small and large intestines but which can occur anywhere in the digestive system between the mouth and the anus. Named after burrill crohn who described the disease in 1932. The disease often strikes persons in their teens or early twenties. It tends to be chronic, recurrent with periods of remission and exacerbation. In the early stages. It causes small scattered shallow crater-like areas (erosions) called apthous ulcers in the inner surface of the bowel. With time, deeper and larger ulcers develop, causing scarring and stiffness of the bowel and the bowel becomes increasingly narrowed, leading to obstruction. Deep ulcers can puncture holes in the bowel wall, leading to infection in the abdominal cavity (peritonitis) and in adjacent organs abdominal pain, diarrhoea, vomiting, fever, and weight loss can be symptoms. Crohn's disease can be associated with reddish tender skin nodules, and inflammation of the joints, spine, eyes, and liver. Diagnosis is by barium enema, barium X-ray of the small bowel, and colonoscopy. Treatment includes medications for inflammation, immune suppression, antibiotics, or surgery.
(12 Dec 1998)
telomere terminal transferase <enzyme> From oxytricha nova; adds two to seven tandem repeats of the sequence ggggtttt to the 3' end of oligonucleotide primers ending in repeats of g4t4 and always adds the repeats in the proper phase
Registry number: EC 2.7.7.-
(26 Jun 1999)
terminal 1. Forming or pertaining to an end, placed at the end.
2. A termination, end or extremity.
Origin: L. Terminalis
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á